Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4317 Target Snapshot

5-hydroxytryptamine receptor 4 · SINGLE PROTEIN · Rattus norvegicus

372Compounds
95Assays
6Approved Drugs
409.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q62758. Use UniProt Q62758 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q62758 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 4 as ChEMBL target CHEMBL4317, mapped to UniProt Q62758. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 4
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL4317
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q62758
5-hydroxytryptamine receptor 4
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 4 is the right protein anchor across sources, using UniProt Q62758 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 4
UniProt AccessionQ62758
Component TypeProtein
Sequence Length406 aa

5-hydroxytryptamine receptor 4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 4, mapped to UniProt Q62758. Sequence length is 406 aa.

Mapped IDQ62758
Review name5-hydroxytryptamine receptor 4
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

6
Approved
6
Phase III
3
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC509.0
KI289.0
EC5095.0
KD16.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3126108 10.15 Ki 0.07 Preclinical
CHEMBL3221572 10.09 Ki 0.081 Preclinical
CHEMBL329487 9.96 Ki 0.1096 Preclinical
CHEMBL315071 9.89 Ki 0.13 Preclinical
CHEMBL3221571 9.82 Ki 0.15 Preclinical
CHEMBL33884 9.82 Ki 0.15 Preclinical
CHEMBL3126109 9.7 Ki 0.2 Preclinical
CHEMBL155917 9.59 Ki 0.26 Preclinical
CHEMBL50660 9.59 Ki 0.26 Preclinical
CHEMBL262950 9.54 Ki 0.2884 Preclinical
Distribution

pChEMBL Value Distribution

5
5.0
8
5.5
39
6.0
42
6.5
53
7.0
42
7.5
34
8.0
37
8.5
19
9.0
16
9.5
pChEMBL
Approved Drugs

Approved Drugs

VILAZODONE
CHEMBL439849
Approved 2011
PRUCALOPRIDE
CHEMBL117287
Approved 2009
CISAPRIDE
CHEMBL1729
Approved 1993
METOCLOPRAMIDE
CHEMBL86
Approved 1979
Assay Landscape

Assay Landscape

95
Total Assays
162
Tested Compounds
2
Assay Types
Functional — 53 assays, 67 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 21 36 7.2
tissue-based format 13 26 7.3
cell-based format 11 4 8.8
organism-based format 6 0
single protein format 2 1 7.7
Binding — 42 assays, 162 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 13 93 7.9
single protein format 13 14 6.8
tissue-based format 9 33 7.3
assay format 4 19 7.2
cell-based format 3 3 8.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine